Study on the effectiveness and impact of pentavalent vaccination program in India and other south Asian countries

  • S. S
  • A. A
  • N. P
  • 2


    Mendeley users who have this article in their library.
  • N/A


    Citations of this article.


Penta-valent-vaccine is a combination vaccine administered in a 3-dose schedule, offers protection against diphtheria, tetanus, pertussis (DPT), hepatitis B, and Haemophilus influenza type B (Hib). The vaccine is widely recommended by WHO and GAVI as a substitute for prevailing vaccination practices against the above mentioned diseases and viruses. The vaccine has met with both positive and negative responses, which leads to uncertainties about the vaccine's safety. The pros and cons of the vaccine are to be evaluated carefully before the same is added to routine immunization schedule.

Author-supplied keywords

  • BCG vaccine
  • Bhutan
  • India
  • Pakistan
  • South Asian
  • Sri Lanka
  • Viet Nam
  • article
  • clinical effectiveness
  • crying
  • diphtheria
  • diphtheria pertussis tetanus Haemophilus influenza
  • diphtheria pertussis tetanus hepatitis B vaccine
  • diphtheria pertussis tetanus vaccine
  • drug fatality
  • drug safety
  • drug withdrawal
  • epidemic
  • fever
  • government
  • hepatitis B
  • human
  • immunization
  • immunogenicity
  • incidence
  • influenza B
  • injection site coloration
  • injection site pain
  • injection site swelling
  • irritability
  • muscle hypotonia
  • pertussis
  • pilot study
  • poliomyelitis
  • prevalence
  • side effect
  • tetanus
  • vaccination

Get free article suggestions today

Mendeley saves you time finding and organizing research

Sign up here
Already have an account ?Sign in

Find this document


  • Sreedhar S.

  • Antony A.

  • Poulose N.

Cite this document

Choose a citation style from the tabs below

Save time finding and organizing research with Mendeley

Sign up for free